AI Insight
Researchers at McMaster University have discovered that the hormone GDF15, previously known primarily for its role in appetite suppression and weight loss, can protect the liver from inflammation and scarring through a mechanism independent of weight reduction. The study reveals that GDF15 activates a previously unidentified brain-to-liver pathway that stimulates the release of glucocorticoids, which help reduce immune activity in the liver. This finding suggests the hormone has dual functions, with liver protection occurring through a distinct biological pathway separate from its metabolic effects.
Why it matters
This discovery could lead to new therapeutic approaches for treating liver diseases such as non-alcoholic fatty liver disease and liver fibrosis, particularly for patients who cannot achieve significant weight loss. The identification of this brain-to-liver pathway opens possibilities for targeted treatments that harness the liver-protective benefits of GDF15 without necessarily relying on weight reduction as the primary mechanism.
Understand the Science
A hormone already known for curbing appetite and supporting weight loss may have a surprising second job: protecting the liver from inflammation and scarring. Researchers at McMaster University found that GDF15 activates a previously unknown brain-to-liver pathway that triggers the release of glucocorticoids, helping calm immune activity in the liver.
Source: This weight-loss hormone may protect the liver even without weight loss